Safe Pro Group expects Q3 2026 revenue above $2.5 million, up over 2,300%, driven by U.S. government subcontract awards and ...

Esperion reached a settlement restricting Renata’s U.S. generic NEXLETOL and NEXLIZET launches until April 19, 2040, subject ...

Google and Unity announced a strategic partnership launching Playground and Unity Spark to revolutionize game creation with ...

Aehr Test Systems (NASDAQ:AEHR) received $6 million in follow-on production orders for its Sonoma package-level burn-in ...

Seaport Therapeutics (NASDAQ:SPTX) dosed the first patient in an Australian Phase 2a trial evaluating GlyphAgo for ...

OR Royalties (NYSE:OR) reported preliminary Q3 2026 royalty and stream revenues of $90.205 million, driven by deliveries of ...

Nurix Therapeutics (NASDAQ:NRIX) enrolled the first patient in its Phase 1b/2 study evaluating bexobrutideg with venetoclax ...

Figure Technology Solutions (NASDAQ:FIGR) reported preliminary Q3 consumer loan marketplace volume of $5,119 million, a 107% ...

Oculis (NASDAQ:OCS) to present Licaminlimab at Eyecelerator @ AAO 2026 on October 8, with topline results from the PREDICT-1 ...

Cosmos Health (NASDAQ:COSM) reported preliminary nine-month 2026 revenue of $54.3 million, up 19% year over year, and ...

Lakewood-Amedex reported preclinical Bisphosphocin results, including up to 97% E. coli inhibition in an animal urinary tract ...

Lucas GC (NASDAQ:LGCL) reported first-half 2026 revenue of US$35.74 million, highlighting higher gross and net margins amid ...